Cargando…

Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome

BACKGROUND: Oral progestin has recently been used to prevent premature LH surges in ovarian stimulation, and this progestin-primed ovarian stimulation (PPOS) is effective and safe in patients with different ovarian reserves. The current data are lacking regarding how to individualize the gonadotropi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Hongjuan, Tian, Hui, He, Wen, Lyu, Qifeng, Kuang, Yanping, Chen, Qiuju, Sun, Lihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971418/ https://www.ncbi.nlm.nih.gov/pubmed/29807533 http://dx.doi.org/10.1186/s12958-018-0373-7

Ejemplares similares

Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study
por: Lin, Yue, et al.
Publicado: (2021)

Editorial: Recent advances in progestin-primed ovarian stimulation
por: Chen, Qiuju
Publicado: (2022)

Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study
por: Liu, Ahui, et al.
Publicado: (2022)

Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma
por: Yang, Ai-Min, et al.
Publicado: (2022)

A delayed ovulation of progestin-primed ovarian stimulation (PPOS) by downregulating the LHCGR/PGR pathway
por: Xie, Yating, et al.
Publicado: (2023)

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
por: Huang, Haipeng, et al.
Publicado: (2022)

Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures
por: Shen, Xi, et al.
Publicado: (2020)

Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol
por: Li, Danjun, et al.
Publicado: (2022)

The Comparison of Fixed and Flexible Progestin Primed Ovarian Stimulation on Mature Oocyte Yield in Women at Risk of Premature Ovarian Insufficiency
por: Kalafat, Erkan, et al.
Publicado: (2022)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
por: Zhang, Junwei, et al.
Publicado: (2021)

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2022)

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017)

Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results
por: Shibasaki, Sena, et al.
Publicado: (2023)

Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study
por: Filippi, Francesca, et al.
Publicado: (2023)

A Higher Estradiol Rise After Dual Trigger in Progestin-Primed Ovarian Stimulation Is Associated With a Lower Oocyte and Mature Oocyte Yield in Normal Responders
por: Huang, Jialyu, et al.
Publicado: (2019)

Optimal Ovulation Trigger–Oocyte Pickup Interval in Progestin-Primed Ovarian Stimulation Protocol: A Retrospective Study Using Propensity Score Matching
por: Shen, Xi, et al.
Publicado: (2019)

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
por: Liang, Zhou, et al.
Publicado: (2020)

Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol
por: Wu, Shuxie, et al.
Publicado: (2023)

Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2023)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Body Mass Index Showed No Impact on the Outcome of In Vitro Fertilization in Progestin-Primed Ovarian Stimulation Protocol
por: Yang, Zhe, et al.
Publicado: (2021)

Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
por: Pai, Angel Hsin-Yu, et al.
Publicado: (2023)

Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study
por: Peng, Qian, et al.
Publicado: (2019)

Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis
por: Zhang, Junwei, et al.
Publicado: (2023)

Lipidomic Components Alterations of Human Follicular Fluid Reveal the Relevance of Improving Clinical Outcomes in Women Using Progestin-Primed Ovarian Stimulation Compared to Short-Term Protocol
por: Wen, Xiaowei, et al.
Publicado: (2018)

Effect of Frozen Embryo Transfer and Progestin-primed Ovary Stimulation on IVF outcomes in women with high body mass index
por: Wang, Li, et al.
Publicado: (2017)

Progestin-Primed Ovarian Stimulation Protocol for Patients in Assisted Reproductive Technology: A Meta-Analysis of Randomized Controlled Trials
por: Guan, Shaogen, et al.
Publicado: (2021)

Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study
por: Huang, Jialyu, et al.
Publicado: (2019)

The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
por: Lin, Guangyao, et al.
Publicado: (2023)

Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study
por: Wang, Ningling, et al.
Publicado: (2018)

Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis
por: Du, Mingze, et al.
Publicado: (2021)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis
por: Yang, Liu, et al.
Publicado: (2023)

Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First In Vitro Fertilization Cycle: A Retrospective Cohort Study
por: Tu, Xiaoyu, et al.
Publicado: (2022)

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study
por: Du, Mingze, et al.
Publicado: (2023)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
por: Zhou, Ruiqiong, et al.
Publicado: (2023)

Combination of pioglitazone and clomiphene citrate versus clomiphene citrate alone for infertile women with the polycystic ovarian syndrome
por: Amirian, Maliheh, et al.
Publicado: (2021)

Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders
por: Chen, Qiuju, et al.
Publicado: (2017)

Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol
por: Chen, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e1fpbj8lmfq822q8i0mt1e2uke